We recently compiled a list of the 10 Worst Performing NASDAQ Stocks in 2024. In this article, we are going to take a look at ...

Over the past five years, diabetes-focused medical device specialist DexCom ( DXCM -0.50%) has made meaningful progress on several fronts. The company launched new products in the continuous glucose ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A robust ...

“Since Dexcom G6 came to market, we’ve eliminated over 15 billion fingerpricks and helped improve the lives of more than 1.25 million people around the world,” claimed Dexcom Australia ...

one of the two major diabetes care companies and maker of the Dexcom G6 and G7, which measure blood sugar continuously like ...

today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by astronauts in space as part of the Polaris Dawn mission, which launched this morning and aims to better ...

Kessler Topaz Meltzer & Check, LLP encourages DexCom investors who have suffered significant losses to contact the firm directly to acquire more information. CLICK HERE TO SIGN UP FOR THE CASE OR GO ...

DexCom's key Q3 earnings factors include Stelo sales, updates on sales channels, and potential share buybacks. See why I ...

Dexcom's G7 product is significantly less expensive, offer a thinner profile, and faster warm-up time than G6. Medicare's decision to reimburse for the G6 and G7 is a favorable development for ...

Valeo Financial Advisors LLC raised its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 31.8% in the third ...

RLF Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights ...

In June, DexCom announced the integration of its G6 CGM system with Insulet’s Omnipod 5 Automated Insulin Delivery System for Type 1 diabetes patients. The same month, the company announced the ...